Responses to single-dose thrombopoietin decrease with higher platelet counts in mice
E Kelemen1, D Lehoczky, K Jakab
1National Institute of Haematology and Immunology, Semmelweis University Medical School, Budapest, Hungary.
Acta Haematologica
|March 23, 1999
Summary
Human serum and recombinant human TPO (rHuTPO) can induce thrombocytosis in mice. However, responses vary, suggesting an unknown endogenous mechanism regulates platelet production beyond TPO levels.
Area of Science:
- Hematology
- Immunology
Background:
- Thrombopoietin (TPO) is a key regulator of platelet production.
- Altered thrombocytopoiesis can lead to abnormal platelet counts.
- Previous studies (pre-1970) hinted at complex regulation of platelet levels.
Purpose of the Study:
- To investigate the thrombocytosis-inducing capacity of human serum from individuals with altered thrombocytopoiesis.
- To explore the role of endogenous mechanisms in response to thrombopoietin (TPO).
- To analyze the effect of single versus repeated doses of recombinant human TPO (rHuTPO) on platelet counts in mice.
Main Methods:
- Administering human serum samples from individuals with altered thrombocytopoiesis to recipient mice.
- Administering single doses of recombinant human TPO (rHuTPO) to random-bred CFLP mice.
- Mixing thrombopoietically active human sera with platelet-free normal serum.
Main Results:
- Variable thrombocytosis observed in mice receiving human serum, even with identical samples.
- Single doses of rHuTPO in mice showed variable responses, inversely correlating with initial platelet levels.
- Mixing active human serum with normal serum reduced thrombocytosis-inducing capacity.
- Repeated pharmacological doses of TPO obscured physiological control mechanisms.
Conclusions:
- Mouse response to exogenous rHuTPO is influenced by an unknown endogenous homeostatic mechanism.
- Platelet count regulation involves more than just TPO levels.
- Physiological control mechanisms are masked by repeated high-dose TPO administration.
